American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
KE
Keen Vision Acquisition Corp.
$12.20
+0.00%
NASDAQ: KVAC · 15-min delayed
$67.2MMarket cap
$1.9MNet income
KVACNASDAQ
2023IPO
About Keen Vision Acquisition Corp.
Keen Vision Acquisition Corp is a blank check company.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Net income
- $1.9M
- Total assets
- $57.0M
- Market cap
- $67.2M
Source: SEC EDGAR · updated Jun 8, 2026
Multi-year
Revenue & profit trend
FY2023
FY2024
FY2025
Revenue Net income
FY 2025
Financial statements
Income statement
- Net income
- $1.9M
Balance sheet
- Total assets
- $57.0M
- Current assets
- $36.8K
- Total liabilities
- $7.0M
- Current liabilities
- $4.1M
- Shareholders’ equity
- -$7.0M
Cash flow
- Operating cash flow
- -$784.1K
- Investing cash flow
- $16.0M
- Financing cash flow
- -$15.3M
- Net cash flow
- -$43.3K
Statements via Polygon.io (SEC filings)
NASDAQ: KVAC
$12.20
+0.00%
15-minute delayed · data by Polygon.io
Past year
$11.25
$12.46
52-week range
- Market cap
- $67.2M
- Shares outstanding
- 5.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 15, 2023
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Profitable — net income of $1.9M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Keen Vision Acquisition Corp..
Write a review
Newsroom
News about Keen Vision Acquisition Corp.
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – NHHS, KVAC, AMPS, AVTE
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
Medera, Inc. to Participate in Two Upcoming Investor Conferences
News & sentiment via Polygon.io
Explore
Browse all →
